Related Experiment Video

Updated: Jul 14, 2026

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2

Odete Mendes1, Hun-Taek Kim, Gina Lungu

  • 1Department of Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843, USA.

Clinical & Experimental Metastasis
|May 17, 2007
PubMed

Insights

Matrix metalloproteinase 2 (MMP2) is crucial for breast cancer (BC) metastasis. Inhibiting MMP2 reduced BC brain metastasis in a rat model, suggesting MMP2 and astrocyte signaling pathways as potential therapeutic targets.

Area of Science:

  • Oncology
  • Neuroscience
  • Biochemistry

Background:

  • Matrix metalloproteinase 2 (MMP2) is implicated in breast cancer (BC) invasion and metastasis.
  • BC brain metastases exhibit high MMP2 expression and activity.
  • The precise role of MMP2 in brain metastasis remains under investigation.

Purpose of the Study:

  • To investigate the role of MMP2 in the development of BC brain metastasis.
  • To explore the involvement of astrocyte reactivity and the MAPK/ERK pathway in BC brain metastasis.

Main Methods:

  • Breast cancer cells (ENU1564) were transfected with tissue inhibitor of MMP2 (TIMP2).
  • Orthotopic tumor growth and metastatic behavior were assessed in vivo.
  • MMP2 activity was measured by gel zymography.
  • Astrocyte-conditioned media and MEK inhibitor (PD98059) were used to study signaling pathways.

Main Results:

  • ENU1564-TIMP2 cells showed reduced tumor growth, metastasis, and no brain metastases.
  • BC brain metastases displayed astrocyte reactivity and increased glial fibrillary acidic protein (GFAP) and phosphorylated-ERK1/2 (p-ERK1/2).
  • Astrocyte-conditioned media enhanced cancer cell invasion, MMP2, and p-ERK1/2 expression.
  • MEK inhibition decreased MMP2 expression in cancer cells exposed to astrocyte factors.

Conclusions:

  • MMP2 plays a significant role in BC metastasis, particularly to the brain.
  • Astrocyte-derived factors and the ERK1/2 signaling pathway are associated with BC brain metastasis.
  • ERK1/2 signaling may regulate MMP2 expression in a manner influenced by astrocytes, offering potential therapeutic targets.

More Related Videos

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...